Stocks like Opko Health Inc [OPK] still have plenty of sunny days ahead

Stocks of Opko Health Inc (NASDAQ:OPK) traded higher last session on Wall Street, up 4.00% to $1.56.

OPK stock price is now 2.13% away from the 50-day moving average and 7.49% away from the 200-day moving average. The market capitalization of the company currently stands at $1.06B.

With the price target maintained at $2, Barrington Research recently Upgraded its rating from Mkt Perform to Outperform for Opko Health Inc (NASDAQ: OPK). On December 15, 2022, H.C. Wainwright recently initiated its ‘Buy’ rating on the stock quoting a target price of $3, while ‘Barrington Research’ rates the stock as ‘Mkt Perform’

In other news, FROST PHILLIP MD ET AL, CEO & Chairman bought 47,537 shares of the company’s stock on Jan 28 ’25. The stock was bought for $70,060 at an average price of $1.47. Upon completion of the transaction, the CEO & Chairman now directly owns 213,234,014 shares in the company, valued at $332.65 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 17 ’25, CEO & Chairman FROST PHILLIP MD ET AL bought 150,000 shares of the business’s stock. A total of $220,425 was incurred on buying the stock at an average price of $1.47. This leaves the insider owning 213,186,477 shares of the company worth $332.57 million. A total of 54.79% of the company’s stock is owned by insiders.

During the past 12 months, Opko Health Inc has had a low of $0.86 and a high of $1.76. As of last week, the company has a debt-to-equity ratio of 0.37, a current ratio of 2.97, and a quick ratio of 2.69. The fifty day moving average price for OPK is $1.5286 and a two-hundred day moving average price translates $1.44985 for the stock.

The latest earnings results from Opko Health Inc (NASDAQ: OPK) was released for 2024-09-30. The net profit margin was -18.80% and return on equity was -9.39% for OPK. The company reported revenue of $173.63 million for the quarter, compared to $178.59 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -2.78 percent.

Related Posts

Fosters Research
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.